MET and lung adenocarcinoma: Next, we first demonstrated that an increased expression of MET in both lung adenocarcinoma and lung squamous cell carcinoma (Figure 2A) from TCGA database analysis (TCGA Research Network: https://www.cancer.gov/tcga), indicating that MET activation in both subtypes of lung cancer.